These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6397985)

  • 1. [Clinical evaluation of Azapentacene in senile cataract--a double-blind controlled study].
    Fukushi S; Irinoda K; Ishikawa S; Miyata M; Watanabe H; Yonechi K; Sato Y; Suzuki T; Asano T; Mizuno K
    Nippon Ganka Gakkai Zasshi; 1984 Dec; 88(12):1528-47. PubMed ID: 6397985
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effect of 2-mercaptopropionyl-glycine (Thiola) for senile cataract].
    Matsuura H; Watanabe T; Kurimoto S
    Nihon Ganka Kiyo; 1969 Dec; 20(12):1173-82. PubMed ID: 4904704
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of the inhibitory effect of Quinax on the progression of senile cataract].
    Prost M; Toczołowski J
    Klin Oczna; 1982 Mar; 84(3):71-2. PubMed ID: 6757553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the effectiveness of Quinax in the prevention of the development of senile cataract].
    Stankiewicz A; Poppe E; Stasiewicz B; Gołebiowska-Hrycukowa A
    Klin Oczna; 1990 Aug; 92(3-4):52-4. PubMed ID: 2263035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Thiola eye drop in senile cataract].
    Imaizumi K; Atsumi K; Tanaka J; Hatano M; Imaizumi S
    Ganka; 1971 Aug; 13(8):790-4. PubMed ID: 4939649
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of tiopronin on senile cataracts. A double-blind clinical study.
    Ichikawa H; Imaizumi K; Tazawa Y; Obara Y; Ishikawa Y; Tobari I; Tanabe Y
    Ophthalmologica; 1980; 180(5):293-8. PubMed ID: 7010262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An eye-lotion of aspartate upon senile cataract].
    Oishi M; Fujii S; Takahashi K
    Nihon Ganka Kiyo; 1966 Aug; 17(8):822-7. PubMed ID: 6008804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Double-blind study on the effectiveness of potassium iodide in the treatment of senile cataract].
    Mayer H; Irion KM
    Fortschr Ophthalmol; 1985; 82(6):520-3. PubMed ID: 4093097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of taurine therapy in senile cataracts].
    Vodovozov AM; Glotova NM
    Vestn Oftalmol; 1981; (2):44-5. PubMed ID: 7233685
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of 'Caracsol' (sodium-iodide in phospho-mono-calcic vehicle) in cases of incipient senile cataract.
    Consul BN; Mahrotra AS; Mathur GB
    Indian Pract; 1967 Jul; 20(7):527-30. PubMed ID: 6065036
    [No Abstract]   [Full Text] [Related]  

  • 11. [Objective evaluation of cataract development under treatment with cytochrome C, sodium succinate, adenosine, nicotinamide and sorbitol].
    Mayer H; König H
    Fortschr Ophthalmol; 1987; 84(3):261-4. PubMed ID: 3040558
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of effectiveness of Catalin eyedrops in patients with presenile and senile cataract].
    Kociecki J; Załecki K; Wasiewicz-Rager J; Pecold K
    Klin Oczna; 2004; 106(6):778-82. PubMed ID: 15787181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption of brimonidine 0.1% and 0.15% ophthalmic solutions in the aqueous humor of cataract patients.
    Cantor LB; WuDunn D; Catoira-Boyle Y; Yung CW
    J Glaucoma; 2008; 17(7):529-34. PubMed ID: 18854728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservative treatment potentials in initial senile cataract].
    Larionov LN
    Vestn Oftalmol; 1980; (5):49-51. PubMed ID: 7423731
    [No Abstract]   [Full Text] [Related]  

  • 15. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients.
    Babizhayev MA; Micans P; Guiotto A; Kasus-Jacobi A
    Am J Ther; 2009; 16(6):517-33. PubMed ID: 19487926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the preparation quinax in the trial treatment of senile and secondary cataract].
    Zygulska-Mach H; Pioruńska M; Paziewski E
    Wiad Lek; 1982 Nov; 35(19-20):1239-43. PubMed ID: 6761971
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect on ocular blood flow of Combigan® versus placebo in patients with ocular hypertension].
    Puerto-Hernández B; Rebolleda G; García-Pérez JL; Muñoz-Negrete FJ; González-Gordaliza C
    Arch Soc Esp Oftalmol; 2011 Feb; 86(2):42-6. PubMed ID: 21440829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy of cataract (evaluation of Catalin).
    Angra SK; Mohan M; Saini JS
    Indian J Ophthalmol; 1983 Jan; 31(1):5-8. PubMed ID: 6354928
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical use of topical glutathione for cataract].
    Kandori F; Kurimoto S; Fukunaga K; Suyama T; Honda I
    Nippon Ganka Gakkai Zasshi; 1967 Jun; 71(6):689-97. PubMed ID: 5624656
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of Bendaline on cataracts.
    Rhee SW; Youn DH; Lee J; Choi O; Jung HR
    Korean J Ophthalmol; 1987 Jun; 1(1):31-4. PubMed ID: 3333943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.